← Back to Search

Oral Chemotherapy Support for Oral Chemotherapy (ON-BOARD Trial)

N/A
Waitlist Available
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five months
Awards & highlights

ON-BOARD Trial Summary

This trial is testing a new way to help people who take oral chemotherapy drugs. The goal is to see if it helps them feel better and take their medication more regularly.

ON-BOARD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five months
This trial's timeline: 3 weeks for screening, Varies for treatment, and five months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility and acceptability
Secondary outcome measures
Potential effects of intervention via medication adherence self-efficacy, medication adherence and symptom distress

ON-BOARD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention plus usual careExperimental Treatment1 Intervention
Group II: Usual care onlyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
394 Previous Clinical Trials
998,329 Total Patients Enrolled
Rossy Cancer NetworkUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for participants still open in this experiment?

"Yes, this trial is still open and looking for patients. The listing on clinicaltrials.gov shows that it was first posted on January 7th, 2022 and was last updated on August 23rd, 2022."

Answered by AI

What is the projected patient volume for this experimental program?

"The data hosted on clinicaltrials.gov verifies that this study is still recruiting patients. This clinical trial was first posted on January 7th, 2022 and was updated on August 23rd, 2022. The study is currently enrolling 52 participants from 1 site."

Answered by AI
~16 spots leftby Apr 2025